MPM BioVentures 2014, L.P. sold $462K of Entrada Therapeutics (TRDA)

Executed Aug 24, disclosed Aug 27, 2 days later.

Value, as filed

$462K

62,714 sh across 3 lots

Executed

Aug 24

the trade date, as filed

Disclosed

Aug 27

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

MP MPM BioVentures 2014, L.P. 10% owner profile →

MPM BioVentures 2014, L.P. (10% owner) filed 4 Form 4 reports as a reporting entity in the trailing twelve months (0 purchases, 4 sales), most often in Entrada Therapeutics, Inc. (TRDA). The largest single filing was $1.9M of TRDA (259,837 sh across 3 lots, as filed), executed Sep 4.

The name

TRDA

Entrada Therapeutics, Inc. TRDA · Healthcare · 31 filings in 24 months ticker →

Healthcare · Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new c…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by MPM BioVentures 2014, L.P. in TRDA

TRDASALE Entrada Therapeutics, Inc. $1.9M
259,837 sh across 3 lots
Exec Sep 4
Filed Sep 9 · 7:23 PM ET TRDASALE Entrada Therapeutics, Inc. $617K
86,482 sh across 3 lots
Exec Sep 1
Filed Sep 3 · 7:21 PM ET TRDASALE Entrada Therapeutics, Inc. $590K
83,181 sh across 2 lots
Exec Aug 27
Filed Aug 31 · 6:25 PM ET